questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of whether NHS England’s projected PET-CT activity volumes for prostate cancer under the forthcoming commissioning arrangements align with current regional activity levels; and what assessment he has made of any variance between projected and existing provision.
answerText: NHS England is responsible for commissioning prostate‑specific membrane antigen (PSMA) radiotracers for positron emission tomography–computed tomography (PET‑CT) imaging for adults with high‑risk primary or recurrent prostate cancer. The commissioning pol...
heading: Prostate Cancer: Screening